Fund News Today — September 8, 2026

FundNews newsroom brief · 35m ago · 2 min read · via FundNews

Pharma major Novartis falls 9% after three drug trial setbacks and more — today's fund signal.

The pharmaceutical industry is facing a significant setback today as Novartis, a major player in the field, has seen its stock plummet nearly 10% after announcing three drug trial setbacks. This news has sent shockwaves through the market, with the Dow being dragged down as a result. The decline of Novartis' stock is not only a concern for investors in the pharmaceutical sector, but also for the broader market, as it highlights the risks and challenges associated with drug development. The fact that a single company's bad news can have such a significant impact on the Dow underscores the interconnectedness of the global economy.

However, it's not all bad news today, as the technology sector is showing signs of strength. TSMC and Samsung, two major players in the chipmaking industry, have committed to using ASML's newest chipmaking tools, driven by the growing demand for artificial intelligence. This development is a positive sign for the industry, as it suggests that companies are investing in the latest technologies to stay ahead of the curve. Meanwhile, other news stories, such as the sale of Chris Evans' L.A. home and the luxurious homes of the Season 35 cast of 'Dancing With the Stars', serve as a reminder that there are other aspects of the economy and popular culture that continue to function independently of the market's ups and downs.

Today's signal:
• Pharma major Novartis falls 9% after three drug trial setbacks (cnbc.com)
• All about the stunning homes of the Season 35 cast of ‘Dancing With the Stars’ (marketwatch.com)
• ‘Captain America’ star Chris Evans sells his L.A. home, but at $1 million under asking price (marketwatch.com)
• Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks (cnbc.com)
• TSMC, Samsung commit to ASML’s newest chipmaking tools as AI drives demand (cnbc.com)
• Why the Dow is being dragged down by a Swiss company’s bad news (marketwatch.com)

Originally reported by FundNews. FundNews curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily fund signal:

More from FundNews

Across the eCorp newsroom network

Part of the eCorp network